Document Detail


Inhalation performance of physically mixed dry powders evaluated with a simple simulator for human inspiratory flow patterns.
MedLine Citation:
PMID:  20628789     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
PURPOSE: To construct a simple simulator reproducing human inspiratory flow patterns and use it to evaluate the inhalation performance of active ingredient particle-carrier particle systems (physically mixed dry powders).
METHODS: Inspiratory flow patterns were collected and analyzed using a flow recorder. The simulator was constructed using an airtight container, a valve, and a connecting tube. Several of the patterns reproduced by the simulator were compared with those recorded. In addition, the influence of inspiratory flow on the inhalation performance of physically mixed dry powders composed of salbutamol sulfate (SS) and coarse lactose monohydrate was investigated using a twin-stage liquid impinger (TSLI) equipped with the simulator.
RESULTS: Human inspiratory flow patterns could be characterized by three parameters: inspiratory flow volume (area under the flow rate-time curve (AUC)), flow increase rate (FIR), and peak flow rate (PFR). The patterns could be reproduced using the simulator. Testing with the simulator in vitro revealed that PFR, but not FIR or AUC, greatly affected the inhalation performance of physically mixed dry powders.
CONCLUSIONS: The simulator is simple to construct and can schematically reproduce human inspiratory flow patterns. Testing with a TSLI and the simulator is useful to evaluate dry powder formulations for clinical application.
Authors:
Daiki Hira; Tomoyuki Okuda; Daisuke Kito; Kazunori Ishizeki; Toyoko Okada; Hirokazu Okamoto
Related Documents :
17220519 - Modeling inspiratory and expiratory steady-state velocity fields in the sprague-dawley ...
3842209 - Concentration of d-propranolol in cervico-vaginal mucus: targeting of a novel spermicide.
8810599 - Shape and position of the complete dose-response curve for inhaled methacholine in norm...
10781129 - Visible and occult blood contamination of laryngeal mask airways and tracheal tubes use...
10328149 - Airway vascular changes in lung allograft recipients.
7352699 - Non-organic acute upper airway obstruction: description and a diagnostic approach.
6434679 - Lecithin:cholesterol acyltransferase and cholesteryl ester transfer activity from the i...
8997539 - Feature discovery and classification of doppler umbilical artery blood flow velocity wa...
21382829 - Control of vortex shedding on two- and three-dimensional aerofoils.
Publication Detail:
Type:  Journal Article     Date:  2010-07-14
Journal Detail:
Title:  Pharmaceutical research     Volume:  27     ISSN:  1573-904X     ISO Abbreviation:  Pharm. Res.     Publication Date:  2010 Oct 
Date Detail:
Created Date:  2010-09-15     Completed Date:  2011-02-02     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  8406521     Medline TA:  Pharm Res     Country:  United States    
Other Details:
Languages:  eng     Pagination:  2131-40     Citation Subset:  IM    
Affiliation:
Faculty of Pharmacy, Meijo University, 150 Yagotoyama Tempaku-ku, Nagoya 468-8503, Japan.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Administration, Inhalation
Adrenergic beta-2 Receptor Agonists / administration & dosage*,  chemistry,  pharmacokinetics*
Albuterol / administration & dosage*,  chemistry,  pharmacokinetics*
Chromatography, High Pressure Liquid
Dry Powder Inhalers*
Humans
Lactose / chemistry
Microscopy, Electron, Scanning
Models, Biological*
Powders
Surface Properties
Chemical
Reg. No./Substance:
0/Adrenergic beta-2 Receptor Agonists; 0/Powders; 18559-94-9/Albuterol; 63-42-3/Lactose

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Apple S locus region represents a large cluster of related, polymorphic and pollen-specific F-box ge...
Next Document:  Old and new molecular mechanisms associated with platelet resistance to antithrombotics.